Medicare links up with private payers, expands colorectal cancer screening benefit
Take note of an expanded benefit for colorectal cancer (CRC) screening. It’s likely to mean that providers will talk to more patients about the screening, billing staff will collect copays from fewer patients, and if your practice performs non-invasive CRC tests in-house, you’ll see an uptick in lab services.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.